Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 12Phase NA 11Phase 3 3Phase 4 2Phase 2/3 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Completed 121Terminated 27Unknown 21Active not recruiting 19Recruiting 13Withdrawn 3Not yet recruiting 3Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 89Breast 54Thoracic 53Gynecologic 28Genitourinary 26Head & Neck 25Lymphoid 20Other hematologic neoplasm 19CNS 12Plasma cell 8Sarcoma 7Tumor-Agnostic 6Dermatologic 6Endocrine 4Myeloid 3Classical hematology 3Other solid neoplasm 1NET 1

Conditions

Lymphoma 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Higher-risk Myelodysplastic Syndrome 1Epstein-Barr Virus Infections 1

Interventions

luspatercept 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × Myeloid × Clear all
NCT07489755 2026-03-24

TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients

Shenzhen TargetRx Co., Ltd.

Phase 3 Not yet recruiting
180 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT06927232 2025-04-15

AZA+Lus VS AZA Monotherapy in HR-MDS

Peking Union Medical College Hospital

Phase 3 Not yet recruiting
86 enrolled
Myeloid

Higher-risk Myelodysplastic Syndrome

NCT05775705 2023-03-20

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

Beijing Friendship Hospital

Phase 3 Not yet recruiting
25 enrolled
LymphoidMyeloid

Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡